Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2015-01-08 11:27 (4187 d 12:00 ago) – Posting: # 14251
Views: 33,718

Dear Cher!

❝ Sorry to ask again, but I can't see any contradiction between point 1 and 3.


Once again slowly to take notes:
Suppose you have a subject with two periods absolved, in both Reference applied.
According to your rules, point 1, you don't have at least one Reference and one Test applied, so you will not include such a subject in the pharmacokinetic and statistical analysis.
Full stop.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
383 visitors (0 registered, 383 guests [including 21 identified bots]).
Forum time: 00:28 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5